María Jesús Lamas Díaz
E-mail : sdaem@aemps.es
María Jesús Lamas has been the Director of the Spanish Agency for Medicines and Health Products (AEMPS) since 2018. She holds a PhD in pharmacy from the University of Santiago de Compostela with a thesis on pharmacogenomics applied to colorectal cancer treatments. As a specialist in hospital pharmacy, she holds certifications in clinical pharmacy in oncology from the Board of Pharmaceutical Specialties and the American Pharmaceutical Association. Previously to her current position, she headed the Pharmacy Service at the University Hospital Complex of Santiago.
Currently, she is the chairperson at the Management Group of the Heads of Medicines Agencies (HMA) and is Spain’s representative on the Management Board of HERA (Health Emergency Preparedness and Response) of the European Commission. Additionally, she is a member of the EMA Management Board, where strategic decisions regarding medicines in Europe are made. She is also a member of the MSSG (Executive Steering Group on Shortages and Safety of Medicinal Products) and the MDSSG (Executive Steering Group on Shortages and Safety of Medical Devices), which works to ensure a robust response to distribution issues arising from emergencies affecting public health, coordinating urgent actions within the European Union to manage supply issues and problems related to the quality, safety, and efficacy of medicines.
As memeber of the ACT-EU Steering Group and Co-chair de the Multistakeholder Platform Advisory Group she is also invoved in improving the clinical trials environment in the European Union through harmonisation, innovation and collaboration with stakeholders.
Furthermore, she is part of the HAG (Heads of HTA Agencies Group), the group of heads of agencies that provides strategic support for the assessment of health technologies in Europe, particularly for the implementation of the Health Technology Assessment Regulation.
Her continuous work to romote innovation through the medicines lifecicle in the EU is reflected in her role as chair in the EU innovation network (EU-IN) and her contributions to the Regulatory science, innovation and competitiveness theme in the European medicines agencies network strategy 2028, which aims to bridge the gap between scientific research and the practical application of that research in regulatory decision making.
Throughout her career, María Jesús Lamas has worked with an unwavering commitment to improving public health and pharmaceutical care, promoting research and innovation in service to patients.